Skip to content

Effects of Surgical Timing on Perioperative Clinical Outcomes in Pancreaticoduodenectomy

Influence of Timing on Outcomes of Pancreaticoduodenectomy: Complications, Hospital Costs, and Length of Stay

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06874660
Enrollment
350
Registered
2025-03-13
Start date
2021-01-01
Completion date
2025-02-20
Last updated
2025-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreaticoduodenal; Fistula, Perioperative Complication, Surgery Timing

Brief summary

With the advancement of surgical techniques and the increase in pancreatic oncologic diseases, the volume of pancreaticoduodenal surgeries has been increasing year by year in our center, and multiple pancreaticoduodenal surgeries are often performed on the day of surgery. This study will compare the effect of pancreaticoduodenal surgery performed at different times on patient prognosis. This study plans to divide the patients into morning group, afternoon group, and night group through the start time of surgery, and this study plans to analyze subgroups such as laparoscopic pancreaticoduodenal surgery. The outcome indicators include perioperative complications such as pancreatic fistula, bleeding, abdominal infection, hospitalization cost, and length of hospital stay. The conclusions drawn from this study will suggest to surgeons whether pancreaticoduodenal surgery performed at different times of the day will have different outcomes for patients and will guide surgeons on the timing of pancreaticoduodenal surgery.

Interventions

None listed

Sponsors

West China Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Patients must be required to sign an informed consent form; 2. Age 18-80 years, male and female; 3. ECOG Physical Status Score (PS Score) 0 or 1. 4. Pancreaticoduodenectomy at our center without contraindications related to the surgery.

Exclusion criteria

1. Pre-existing or concurrent other malignant tumors 2. Severe cardiopulmonary and renal dysfunction. 3. Autoimmune disease or history of immunodeficiency 4. Active infections and infectious diseases requiring systemic therapy. 5. History of psychotropic substance abuse, alcoholism or drug addiction. 6. Failure to meet the inclusion criteria as determined by the investigator.

Design outcomes

Primary

MeasureTime frameDescription
perioperative complicationperioperativepancreatic fistula; postoperative bleeding; abdominal infection; delayed gastric emptying

Secondary

MeasureTime frameDescription
Length of hospitalizationperioperativeLength of admission to surgery; length of surgery; length of postoperative stay to discharge

Other

MeasureTime frameDescription
Cost of hospitalizationperioperativeCost of surgery; cost of postoperative medications; total cost of hospitalization

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026